Organon & Co.
OGN
$7.18
$0.010.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.69% | -1.02% | -0.84% | 2.24% | 4.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.69% | -1.02% | -0.84% | 2.24% | 4.21% |
| Cost of Revenue | 4.75% | 3.81% | 3.31% | 6.88% | 10.67% |
| Gross Profit | -6.29% | -4.44% | -3.71% | -0.88% | 0.03% |
| SG&A Expenses | 4.95% | -1.45% | -3.10% | -2.71% | -11.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.94% | 0.14% | -0.57% | 1.34% | -0.41% |
| Operating Income | -15.78% | -5.05% | -1.75% | 5.32% | 21.38% |
| Income Before Tax | -10.23% | 1.68% | -0.30% | 19.91% | 15.00% |
| Income Tax Expenses | 138.73% | 90.14% | 79.09% | 83.71% | -646.32% |
| Earnings from Continuing Operations | -61.49% | -30.00% | -28.37% | -15.54% | 122.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.49% | -30.00% | -28.37% | -15.54% | 122.39% |
| EBIT | -15.78% | -5.05% | -1.75% | 5.32% | 21.38% |
| EBITDA | -9.11% | -0.30% | 1.61% | 7.05% | 20.29% |
| EPS Basic | -61.89% | -30.57% | -28.91% | -16.11% | 121.09% |
| Normalized Basic EPS | -21.94% | -5.02% | 0.98% | 11.74% | 41.70% |
| EPS Diluted | -62.10% | -31.03% | -29.67% | -16.81% | 120.46% |
| Normalized Diluted EPS | -21.84% | -5.16% | 0.67% | 11.30% | 41.31% |
| Average Basic Shares Outstanding | 0.91% | 0.86% | 0.79% | 0.71% | 0.63% |
| Average Diluted Shares Outstanding | 0.81% | 1.06% | 1.17% | 1.13% | 0.92% |
| Dividend Per Share | -46.43% | -23.21% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.39% | 0.11% | 0.43% | 0.20% | -0.55% |